---
figid: PMC5652078__CCDT-17-637_F2
figlink: /pmc/articles/PMC5652078/figure/F2/
number: F2
caption: "ER and cyclin D–CDK4/6–INK4–Rb pathway cross-talk. AKT, protein kinase B;
  CDK, cyclin-dependent kinase; CoA, co-activator; E2F, E2 transcription factor;
  ER, estrogen receptor; GATA3, GATA-binding protein 3; mTOR, mammalian target of
  rapamycin; P, phosphorylation; PI3K, phosphatidylinositol 3-kinase; pS167, phosphorylated
  serine-167; TFs, transcription factors; Rb, retinoblastoma; S6K, S6 kinase."
pmcid: PMC5652078
papertitle: 'HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action,
  Clinical Activity, and Safety Profiles.'
reftext: Sarah L. Sammons, et al. Curr Cancer Drug Targets. 2017 Sep;17(7):637-649.
pmc_ranked_result_index: '134501'
pathway_score: 0.9704789
filename: CCDT-17-637_F2.jpg
figtitle: 'HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action,
  Clinical Activity, and Safety Profiles.'
year: '2017'
organisms:
- Homo sapiens
ndex: 5b291ac3-dec7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5652078__CCDT-17-637_F2.html
  '@type': Dataset
  description: "ER and cyclin D–CDK4/6–INK4–Rb pathway cross-talk. AKT, protein kinase
    B; CDK, cyclin-dependent kinase; CoA, co-activator; E2F, E2 transcription factor;
    ER, estrogen receptor; GATA3, GATA-binding protein 3; mTOR, mammalian target of
    rapamycin; P, phosphorylation; PI3K, phosphatidylinositol 3-kinase; pS167, phosphorylated
    serine-167; TFs, transcription factors; Rb, retinoblastoma; S6K, S6 kinase."
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND1
  - CDK6
  - E2F6
  - AKT2
  - CDK4
  - E2F3
  - CCND2
  - CCND3
  - E2F5
  - E2F2
  - E2F8
  - GATA3
  - MTOR
  - E2F7
  - E2F4
  - AKT1
  - AKT3
  - E2F1
  - Exemestane
  - Tamoxifen
genes:
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: GATA3
  symbol: GATA3
  source: hgnc_symbol
  hgnc_symbol: GATA3
  entrez: '2625'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
chemicals:
- word: Exemestane
  source: MESH
  identifier: C056516
- word: Tamoxifen
  source: MESH
  identifier: D013629
diseases: []
figid_alias: PMC5652078__F2
redirect_from: /figures/PMC5652078__F2
figtype: Figure
---
